| Cash Flow | 2025-09-30 |
|---|---|
| Net loss | -34,881 |
| Depreciation and amortization | 60,274 |
| Amortization of deferred financing costs | 3,035 |
| Accretion of terminated swap | 0 |
| Amortization of mortgage premiums and discounts, net | 65 |
| Amortization (accretion) of market lease and other intangibles, net | 2,022 |
| Bad debt expense | 659 |
| Equity-based compensation | 1,903 |
| Gain on sale of real estate investments | 28,267 |
| Cash received from non-designated derivative instruments | 2,609 |
| Loss (gain) on non-designated derivative instruments | -46 |
| Impairment charges | 33,752 |
| Gain on extinguishment of debt | 257 |
| Deferred tax valuation allowance | -1,215 |
| Straight-line rent receivable | 2,412 |
| Prepaid expenses and other assets | 7,155 |
| Termination fees payable to related parties | 0 |
| Accounts receivable, net | -4,391 |
| Accounts payable, accrued expenses and other liabilities | -35,838 |
| Deferred leasing costs | 7,182 |
| Deferred rent | 3,013 |
| Net cash used in operating activities | -3,008 |
| Property acquisitions | 250 |
| Capital expenditures | 16,953 |
| Investments in non-designated interest rate caps | 0 |
| Proceeds from sales of real estate investments | 90,340 |
| Net cash provided by investing activities | 73,137 |
| Payments on fannie mae and other secured debt | 26,034 |
| Proceeds from fannie mae and other secured debt | 0 |
| Payments on mortgage notes payable | 645 |
| Payments of deferred financing costs | 205 |
| Proceeds from promissory note | 0 |
| Repurchase of preferred stock | 4,503 |
| Distributions paid on preferred stock-Series ACumulative Redeemable Perpetual Preferred Stock | 5,410 |
| Distributions paid on preferred stock-Series BCumulative Redeemable Perpetual Preferred Stock | 4,752 |
| Distributions to non-controlling interest holders | 139 |
| Net cash (used in) provided by financing activities | -41,688 |
| Net change in cash, cash equivalents and restricted cash | 28,441 |
| Cash and cash equivalents at beginning of period | 74,095 |
| Cash and cash equivalents at end of period | 102,536 |
National Healthcare Properties, Inc. (NHPAP)
National Healthcare Properties, Inc. (NHPAP)